Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $4.0 billion.

  • Accendra Health's Liabilities and Shareholders Equity fell 2056.68% to $4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 billion, marking a year-over-year decrease of 1442.12%. This contributed to the annual value of $4.7 billion for FY2024, which is 858.31% down from last year.
  • Per Accendra Health's latest filing, its Liabilities and Shareholders Equity stood at $4.0 billion for Q3 2025, which was down 2056.68% from $4.2 billion recorded in Q2 2025.
  • Accendra Health's 5-year Liabilities and Shareholders Equity high stood at $5.7 billion for Q1 2022, and its period low was $3.4 billion during Q1 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $5.1 billion (2023), whereas its average is $4.8 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 6833.59% in 2022, then plummeted by 2167.15% in 2025.
  • Quarter analysis of 5 years shows Accendra Health's Liabilities and Shareholders Equity stood at $3.5 billion in 2021, then skyrocketed by 52.3% to $5.4 billion in 2022, then decreased by 5.44% to $5.1 billion in 2023, then dropped by 8.58% to $4.7 billion in 2024, then dropped by 13.31% to $4.0 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $4.0 billion for Q3 2025, versus $4.2 billion for Q2 2025 and $4.9 billion for Q1 2025.